28.51 USD
▼-1.20-4.04%
盘后 27.93 0.00%
2026-09-15
市值
$545.62M
市盈率
—
EPS
-4.56
股息率
—
52 周区间
14.39 – 39.53
成交量
220.90K
Beta
0.22
目标价
77.56
52W 低 14.3952W 高 39.53
价格走势
公司简介
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPC...